GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (OTCPK:ROQAF) » Definitions » Change In Inventory

ROQAF (Roquefort Therapeutics) Change In Inventory : $0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Roquefort Therapeutics Change In Inventory?

Roquefort Therapeutics's change in inventory for the quarter that ended in Jun. 2024 was $0.00 Mil. It means Roquefort Therapeutics's inventory stayed the same from Dec. 2023 to Jun. 2024 .

Roquefort Therapeutics's change in inventory for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means Roquefort Therapeutics's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Roquefort Therapeutics's Total Inventories for the quarter that ended in Jun. 2024 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Roquefort Therapeutics's Days Inventory for the quarter that ended in Jun. 2024 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Roquefort Therapeutics Change In Inventory Historical Data

The historical data trend for Roquefort Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Change In Inventory Chart

Roquefort Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Change In Inventory
- - -

Roquefort Therapeutics Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23 Jun24
Change In Inventory Get a 7-Day Free Trial - - - - -

Roquefort Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roquefort Therapeutics  (OTCPK:ROQAF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Roquefort Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0/0.02*365 / 2
=0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Roquefort Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Roquefort Therapeutics's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roquefort Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Roquefort Therapeutics Business Description

Traded in Other Exchanges
Address
85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses. Its product portfolio consists of MDK Antibody, MDK Oligo, MDK mRNA, STAT-6 siRNA, and MK Cell. The principal activity of the Company is to develop pre-clinical next-generation medicines focused on hard-to-treat cancers.

Roquefort Therapeutics Headlines